Certain Options of AbCellera Biologics Inc. are subject to a Lock-Up Agreement Ending on 9-JUN-2021. These Options will be under lockup for 181 days starting from 10-DEC-2020 to 9-JUN-2021. Details: The officers, directors and substantially all of other securityholders have agreed that they will not offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, lend, or otherwise dispose of, directly or indirectly, any of common shares or securities convertible into or exchangeable or exercisable for any of common shares, enter into a transaction that would have the same effect, or enter into any swap, hedge or other arrangement that transfers, in whole or in part, any of the economic consequences of ownership of common shares, whether any of these transactions are to be settled by delivery of common shares or other securities, in cash or otherwise, or publicly disclose the intention to make any offer, sale, pledge or disposition, or to enter into any transaction, swap, hedge or other arrangement, without, in each case, the prior written consent of Credit Suisse Securities (USA) LLC, Stifel, Nicolaus & Company, Incorporated, Berenberg Capital Markets LLC, SVB Leerink LLC and BMO Capital Markets Corp. for a period of 180 days after the date of this prospectus, subject to certain exceptions.